16th March 2023
Medtrade Products Ltd is delighted to announce that it has entered into an exclusive agreement with Laubscher & Co AG to distribute the revolutionary CELOX™ PPH Uterine Haemostatic Tamponade in Switzerland. CELOX™ PPH offers a unique, CE-certified solution for uterine postpartum haemorrhage (PPH), and Laubscher’s network of Swiss hospitals and...
16th March 2023
Medtrade Products Ltd is delighted to announce that it has entered into an exclusive agreement with Laubscher & Co AG to distribute the revolutionary CELOX™ PPH Uterine Haemostatic Tamponade in Switzerland. CELOX PPH offers a unique, CE-certified solution for uterine postpartum haemorrhage (PPH), and Laubscher’s network of Swiss hospitals...
22nd February 2023
Medtrade Products Ltd is delighted to announce that it has entered into an exclusive agreement with Dahlhausen® Medizintechnik to distribute the revolutionary CELOX™ PPH Uterine Haemostatic Tamponade throughout Austria and Germany. CELOX™ PPH offers a unique, CE-certified solution for uterine postpartum haemorrhage (PPH), and Dahlhausen Medizintechnik’s extensive network will help...
22nd February 2023
Medtrade Products Ltd is delighted to announce that it has entered into an exclusive agreement with Dahlhausen® Medizintechnik to distribute the revolutionary CELOX™ PPH Uterine Haemostatic Tamponade throughout Austria and Germany. CELOX PPH offers a unique, CE-certified solution for uterine postpartum haemorrhage (PPH), and Dahlhausen Medizintechnik’s extensive network will help...
7th November 2022
Medtrade Products Ltd is pleased to announce CE certification for its CELOX™ PPH Uterine Haemostatic Tamponade, a significant and state-of-the-art innovation that provides rapid and effective control of postpartum bleeding, a prevalent and severe complication of childbirth. Gaining accreditation for this game-changing device is a significant medical milestone in the field...
7th November 2022
Medtrade Products Ltd is pleased to announce CE certification for its CELOX™ PPH Uterine Haemostatic Tamponade, a significant and state-of-the-art innovation that provides rapid and effective control of postpartum bleeding, a prevalent and severe complication of childbirth. Gaining accreditation for this game-changing device is a significant medical milestone in the field...
7th July 2022
Russ Mably, our CEO of Medtrade and Celox Medical products, attended an interview on Cat Radio to proudly discuss the highlights of Medtrade and the support provided to the crisis in Ukraine. Medtrade mobilised rapidly reacting to the situation in Ukraine and is manufacturing around the clock to help support...
9th May 2022
New York, May 6, 2022 – As the war in Ukraine enters its third month, journalists facing increased risks in their daily reporting will receive lifesaving medical supplies through a new partnership between the Committee to Protect Journalists and the medical device company Medtrade, the manufacturer of CELOX Hemostatic Technology. The medical supplies,...
17th March 2022
Medtrade Products Ltd are proud to announce the success of receiving the MDR certification for the CELOX CE range of devices alongside MDR Quality Management system certification from BSI. The EU MDR is a medical device regulation that affects all medical devices placed in the European market. Medtrade the parent company...
16th September 2021
Medtrade Products Ltd are proud to announce the successful award of an innovation and research project from the Medical Technology Enterprise Consortium (MTEC NCH – MTEC (mtec-sc.org). Despite fierce competition from numerous different companies, the U.S. Army Medical Material Development Activity (USAMMDA) selected Medtrade Products Ltd to create a product...
11th December 2020
Despite significant developments in scientific understanding and technology, hemorrhage remains the leading cause of preventable trauma related deaths in civilian life and on the battlefield.1-3 The challenges medics face when treating a patient is being unaware of the patients internal conditions through, for example, the use of blood thinners. Another...
25th February 2019
The conflict in Iraq, that began in 2003 and ran until 2011, is arguably one of the most divisive and controversial conflicts in recent memory. No matter how history ultimately looks upon the war, there are several lessons we can take from it, particularly in terms of trauma care in...
Electra House,
Crewe Business Park,
Crewe,
UK,
CW1 6GL
Tel: +44 (0)1270 500019
Email: info@celoxmedical.com
New York – SoHo – Hudson Square,
101 Avenue of the Americas,
8th and 9th Floors,
New York, USA,
NY 10013
Tel: +1 646 417 8452
Email: info@omni-stat.com
This website uses Cookies to improve your browsing experience and to help with our marketing. You can read more about removing Cookies here: Cookie Policy
I'm fine with this